Quick Answer
Vericel Corp reported Research And Development Expense of $27.56 million for the year ending 2025.
- Vericel Corp showed an increase of +11.2% in Research And Development Expense from 2024 to 2025.
- This data is from Vericel Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Vericel Corp's Research And Development Expense has grown by 144.2%.
- Historical annual values: Fiscal year 2025: $27.56 million | Fiscal year 2024: $24.80 million | Fiscal year 2023: $21.04 million | Fiscal year 2022: $19.94 million | Fiscal year 2021: $16.29 million | Fiscal year 2020: $13.02 million | Fiscal year 2019: $30.39 million | Fiscal year 2018: $13.60 million | Fiscal year 2017: $12.94 million | Fiscal year 2016: $15.30 million | Fiscal year 2015: $18.89 million | Fiscal year 2014: $21.26 million | Fiscal year 2013: $15.10 million | Fiscal year 2012: $26.03 million | Fiscal year 2011: $21.33 million | Fiscal year 2010: $12.66 million | Fiscal year 2009: $11.29 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: